Drug information provided by: Merative, Micromedex®
Fidanacogene elaparvovec-dzkt injection is used to treat moderate to severe hemophilia B (congenital Factor IX deficiency) in patients who are using Factor IX treatment, have current or history of life-threatening bleeding, have repeated serious bleeding episodes, or who do not have antibodies to adeno-associated virus serotype Rh74var (AAVRh74var) capsid.
This medicine is to be given only by or under the supervision of your doctor.
This product is available in the following dosage forms:
Portions of this document last updated: July 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?